The future of cat mobility starts now!
2024/09/30 - Products
90% of cats over the age of 10 have joint issues1 which can lead to mobility impairment and impact their quality of life. To keep their joints healthy and improve their mobility, our teams have developed a new Movoflex formula dedicated to cats. A novel soft chew, gradually available in Europe from September 2024.
USA: new partnership with the association for the prevention of pet obesity
2024/09/17 - Products
This September, our American teams formed a strategic alliance with the association for pet obesity prevention (APOP) to confront the growing threat of pet obesity in the United States and raise awareness of the importance of pet nutrition.
2024 half-year results
2024/09/13 - Financial public releases
● Exceptional business momentum in the first half, with revenue up 16.1% at constant exchange rates
● Strong growth in adjusted current operating income1
○ +3.4 points compared with 2023 to reach a record level at 21.4% of revenue
● 2024 targets confirmed
○ Revenue growth expected between 7% and 9% at constant exchange rates and scope
○ Adjusted current operating income1 expected to be around 16% compared with 15.1% in 2023
Capital reduction
2024/09/13 - Financial public releases
Mastitis: a new tool to improve milk quality
2024/08/12 - Products
For several decades, we have been providing industry professionals with solutions to improve milk production. From August 12-14, our teams will be at the National Mastitis Council to present our Smart DCT tool. Its purpose? To make it easier to implement selective dry-off in herds and improve milk quality worldwide.
Over 40 years of commitment to dermatology… and we’re only just getting started!
2024/07/26 - Products
The quality of dogs' and cats' skin and coat is essential for their health and their bond to humans. That’s probably why, since the 80’s, veterinary dermatology has grown to be the primary reason for consultations in pets. At Virbac, we have been part of this history from the outset, working alongside the founding fathers of modern veterinary dermatology, paving the way for innovation for the well-being of our companion animals. This July, as for every edition since the first one, we are principal sponsor of the 10th World Congress of Veterinary Dermatology.
2024 second quarter consolidated sales
2024/07/16 - Financial public releases
Virbac announces executive management changes
2024/07/08 - Press
Sébastien Huron leaves the company, Habib Ramdani takes over while the Group recruits its next chief executive officer
Guidance update for 2024
2024/07/08 - Financial public releases
Our food evolves to better support the oral health of small dogs
2024/06/19 - Products
Small dogs suffer up to five times more oral disease1 than other dogs. To nourish them while taking care of their oral health, our teams have reformulated our Veterinary HPM Small & Toy food. Launched in Europe in June, the new formula now includes a natural ingredient with proven efficacy against plaque, tartar, bleeding gums and bad breath.
Europe: experts meet to talk about canine mobility
2024/06/17 - Products
In June, 10 European veterinary experts in canine mobility met in Nice to share with our teams their experience and knowledge on canine mobility disorders.
Companion animals: first reproductive control guidelines presented!
2024/05/30 - Products
On April 17, our teams, in collaboration with recognized experts, organized a webinar dedicated to the first WSAVA guidelines on reproductive control for dogs and cats. More than 6,000 veterinarians from around the world expressed interest in this important animal health topic.
Latin America: supporting good canine vaccination practices
2024/05/28 - Products
More than 3,500 veterinarians in South America registered for the webinar our teams organized last April. Our goal: to share the latest recommendations on canine vaccination from the World Small Animal Veterinary Association (WSAVA).
Europe: our commitment to fight canine leishmaniosis continues
2024/04/19 - Products
For more than 20 years, our teams have worked to combat this zoonotic disease that threatens the health of dogs and humans alike. In 2024, we continue to work to bring diagnostic, prevention and treatment solutions to veterinarians and dog owners in endemic areas. Our latest stop is France, which will host the Animal Leishmaniosis International Veterinary Event in Nice in April.
2024 first quarter consolidated sales
2024/04/16 - Financial public releases
Virbac acquired Sasaeah, a leading animal health player in Japan.
2024/04/02 - Financial public releases
On April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.
Asia: our teams support growth in canine dermatology
2024/03/28 - Products
As in other parts of the world, around 10%1 of dogs in Asia suffer from atopic dermatitis. Since 2022, our teams have been stepping up their efforts to develop our global DailyDerma program in the region. The goal? To better help Asian veterinarians optimize their dermatology practices and improve the management of skin diseases, especially complex atopic dermatitis.
2023 Annual results
2024/03/19 - Financial public releases
Europe: new prevention solutions for swine farming
2024/03/07 - Products
One year after the launch of Suigen Rota Coli, our teams in France and Germany are now offering a second vaccine for swine, Suigen APP 2,9,11. This new vaccine complements our solutions for the prevention of major swine diseases, helping farmers to better control the health of their farms.
Virbac to take a leading position in Japan through the acquisition of Sasaeah
2024/03/06 - Financial public releases
Virbac announces that it has signed a definitive agreement with ORIX Corporation for the acquisition of its animal health subsidiary Sasaeah for an enterprise value of approximately €280 million.
Virbac: Olivier Charmeil co-opted by the board of directors
2024/01/24 - Career
Virbac announces the appointment of Olivier Charmeil as a new member of the board of directors with effect from December 21, 2023. He replaces Olivier Bohuon, permanent representative of OJB Conseil, within the board of directors and the appointments and compensation committee.
Virbac shampoos for dogs and cats get a makeover!
2024/01/23 - Products
Our range of dermatological (AKI) and hygiene (Allerderm) shampoos has been redesigned to limit ecological impact and simplify use for pet owners. The new packaging is now made from recycled plastic, while the innovative formulations, which have been constantly improved over the last few decades, remain unchanged.
2023 fourth quarter consolidated sales
2024/01/17 - Financial public releases
Happy New Year 2024!
2024/01/08 - Press
Discover the video of Sébastien Huron's wishes to all Virbac teams worldwide.
Dog and cat nutrition: the beginnings of a new approach in China
2023/12/14 - Products
Available in five major Chinese cities since last October, our Veterinary HPM® physiological foods are the only ones in the country to be distributed exclusively in veterinary clinics. This is a novel approach in the region, in line with our medical and scientific approach to animal nutrition.
Pets: a step towards more reasoned pest control
2023/11/23 - Products
Because we are all part of the same ecosystem, parasite control is a necessity which must be carried out while preserving the delicate balance between the health of animals, humans and their environment. With “Let's do it smart”, we provide veterinarians with the tools they need to tailor the solution to the animal's specific needs, thus contributing to a more reasoned use of parasiticides.
Companion animal vaccines: a state-of-the-art production line installed in France
2023/11/17 - Press
A new filling line has been installed in Carros, marking the beginning of the transformation of our production system.
France: Virbac certified as an Authorized Economic Operator
2023/11/10 - Press
At the end of October, the French Customs Department awarded our Group the status of Authorized Economic Operator (AEO): a European customs seal of approval, recognized on the international scene.